Figures and tables index

From the following article

Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL

Klaus W Wagner, Elizabeth A Punnoose, Thomas Januario, David A Lawrence, Robert M Pitti, Kate Lancaster, Dori Lee, Melissa von Goetz, Sharon Fong Yee, Klara Totpal, Ling Huw, Viswanatham Katta, Guy Cavet, Sarah G Hymowitz, Lukas Amler & Avi Ashkenazi

Nature Medicine 13, 1070 - 1077 (2007) Published online: 2 September 2007

doi:10.1038/nm1627

BACK TO ARTICLE
Figure 1 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 1

Specific O-glycosylation enzyme expression correlates with sensitivity to Apo2L/TRAIL.

Full size figure and legend (97 KB)
Figure 2 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 2

Inhibition of O-glycosylation enzymes reduces sensitivity to Apo2L/TRAIL.

Full size figure and legend (79 KB)
Figure 3 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 3

Overexpression of O-glycosylation enzymes promotes sensitivity to Apo2L/TRAIL.

Full size figure and legend (79 KB)
Figure 4 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 4

Modulation of O-glycosylation enzymes affects caspase-8 activation.

Full size figure and legend (78 KB)
Figure 5 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 5

Identification of potential O-glycosylation sites in the ectodomain of DR4 and DR5.

Full size figure and legend (72 KB)
Figure 6 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 6

Inhibition of O-glycosylation impairs Apo2L/TRAIL-induced receptor clustering.

Full size figure and legend (89 KB)
BACK TO ARTICLE